Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 26Terminated 11Recruiting 5Active not recruiting 5Unknown 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Thoracic 2Dermatologic 2Genitourinary 1

Conditions

Melanoma 15Carcinoma, Non-Small-Cell Lung 6Neoplasms 4Uveal Melanoma 3Sarcoma 3Prostatic Neoplasms 3Neoplasm Metastasis 3Pancreatic Neoplasms 2Lung Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous-Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Diseases 1Osteosarcoma 1Neoplastic Cells, Circulating 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1Metastatic Microsatellite Stable Colorectal Cancer 1Kidney Neoplasms 1Hypoxia 1Histiocytoma, Malignant Fibrous 1Head and Neck Neoplasms 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Ipilimumab × Clear all
NCT05150236 2023-12-15

ANZUP2001

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Phase 2 Unknown
93 enrolled
Genitourinary

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Ardigen

Unknown
130 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

NCT04145232 2020-08-10

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Ardigen

Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04169867 2019-11-20

Polish Microbiome Map

Ardigen

Unknown
1,160 enrolled
Dermatologic

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡